China Sky One, which has a history of producing external use and over-the-
counter drugs, has recently acquired pharmaceutical companies that develop and
produce prescription drugs. As a result, prescription drugs manufactured by
China Sky One have doubled and now make up approximately 30% of its total
product lines. Harbin Baolong Pharmaceutical Company, which has an extensive
distribution network for prescription drugs in
The agreement, which initially runs over five years, has a total estimated
value of approximately
"We are excited to be cooperating with Harbin Baolong Pharmaceutical
Company," said Mr.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a
Safe Harbor Statement
Certain of the statements made in the press release constitute forward-
looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These statements can be identified by the use of forward-
looking terminology such as "believe," "expect," "may," "will," "should,"
"project," "plan," "seek," "intend," or "anticipate" or the negative thereof
or comparable terminology. Such statements typically involve risks and
uncertainties and may include financial projections or information regarding
our future plans, objectives or performance. Actual results could differ
materially from the expectations reflected in such forward-looking statements
as a result of a variety of factors, including the risks associated with the
effect of changing economic conditions in
For more information, please contact:
Company Contact:
China Sky One Medical, Inc.
Ms. Yanwei Zhang, Board Secretary
Tel: +86-451-5399-4064
Email: cntiandiren@yahoo.com.cn
Investor Relations Contact:
CCG Investor Relations
Mr. Crocker Coulson, President
Tel: +1-646-213-1915
Email: crocker.coulson@ccgir.com
Mr. Richard Micchelli, Financial Writer
Tel: +1-646-454-4516
Email: richard.micchelli@ccgir.com
Web: http://www.ccgir.com
SOURCE China Sky One Medical, Inc.